癌症中的克洛托:潜在的诊断和预后应用
Jucileide Mota1, Alice Marques Moreira Lima2, Jhessica I S Gomes1
1Post-Graduate Programme in Adult Health (PPGSAD), Federal University of Maranhão, São Luís 65085-580, Brazil.
Diagnostics (Basel, Switzerland)
|November 14, 2023
概括
克洛托蛋白显示出作为癌症生物标志物的前景. 阿尔法克洛托表明更好的预后,而马克洛托表明瘤的攻击性增加,有助于诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 克洛托蛋白 (αKlotho, βKlotho, γKlotho) 具有抑制瘤的功能.
- 人们对克洛托蛋白作为各种疾病的诊断和预后生物标志物越来越感兴趣.
- 最近与癌症相关的Klotho研究分散,需要综合分析.
研究的目的:
- 从2012年到2022年,审查克洛托蛋白在癌症中的作用.
- 评估Klotho蛋白质作为诊断/预后癌症生物标志物.
- 在瘤学中整合目前关于Klotho的发现.
主要方法:
- 来自Cochrane和Scopus数据库 (2012-2022) 的研究文章的系统审查.
- 分析的重点是克洛托在各种癌症类型和生物标志物潜力的作用.
- 精选26篇相关文章,涵盖13种癌症类型.
主要成果:
- 阿尔法-克洛托连续与改善预后和患者存活率有关.
- 在一项研究中,可溶性αKlotho显示了食道癌诊断的潜力.
- 玛-克洛托与膀,乳腺和前列腺癌的攻击性增加有关;β-克洛托的结果是混合的.
结论:
- 克洛托蛋白代表了瘤学中的潜在诊断和预后生物标志物.
- 阿尔法-克洛托可能有助于预测患者的生存率和癌症预后.
- 需要进一步的研究来确定特定的瘤亚型,以实现最佳的基于Klotho的测试开发.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
15.9K
相关概念视频
01:21Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K